42 results on '"Virlogeux, Victor"'
Search Results
2. Effectiveness of Live Poultry Market Interventions on Human Infection with Avian Influenza A(H7N9) Virus, China
3. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis
4. Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: Impact of drug concentration on viral load decay
5. Extrahepatic Manifestations of Chronic Hepatitis B Infection
6. Data from Replication and Heritability of Prostate Cancer Risk Variants: Impact of Population-Specific Factors
7. Supplementary Tables 1-2; Supplementary Figures 1-3 from Replication and Heritability of Prostate Cancer Risk Variants: Impact of Population-Specific Factors
8. Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases
9. Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen – The ANRS CO20-CUPIC study
10. Brief Report : Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection
11. Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model
12. Estimating the Distribution of the Incubation Periods of Human Avian Influenza A(H7N9) Virus Infections
13. Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence data
14. Association between severity of MERS-CoV infection and incubation period
15. Direct-acting antiviral treatments of hepatitis C virus (HCV) : treatment optimization and impact on natural history and epidemiology
16. Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence data
17. Epidemiology and Elimination of HCV-Related Liver Disease
18. Epidemiology and elimination of hcv-related liver disease
19. Additional file 2: Figure S1. of Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
20. Additional file 4: Figure S3. of Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
21. Additional file 8: Figure S7. of Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
22. Additional file 5: Figure S4. of Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
23. Additional file 6: Figure S5. of Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
24. Additional file 3: Figure S2. of Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
25. Additional file 1: of Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
26. Effectiveness of Live Poultry Market Interventions on Human Infection with Avian Influenza A(H7N9) Virus, China.
27. Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
28. 295 - Sustained Virologic Response (SVR) to Direct-Acting Antiviral (DAA) Therapy in Patients with Hepatitis C Virus (HCV) Infection and Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis
29. Incidence and Risk Factors of Coagulation Profile Derangement After Liver Surgery
30. Evaluation of animal-to-human and human-to-human transmission of influenza A (H7N9) virus in China, 2013–15
31. Direct‐acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
32. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia
33. Pour une démocratie socio-environnementale : cadre pour une plate-forme participative « transition écologique »
34. Association between the Severity of Influenza A(H7N9) Virus Infections and Length of the Incubation Period
35. Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.
36. Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
37. Brief Report
38. Replication and Heritability of Prostate Cancer Risk Variants: Impact of Population-Specific Factors
39. Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis
40. Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring
41. The growing dilemma of peer review: a three-generation viewpoint.
42. Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.